Search results

  1. Neurological conditions

    Everything NICE has said on neurological conditions in an interactive flowchart

  2. Suspected neurological conditions: recognition and referral (QS198)

    This quality standard covers assessing and referring children (under 16) and adults (16 and over) who have symptoms or signs associated with neurological conditions. It describes high-quality care in priority areas for improvement.

  3. Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer (TA668)

    Evidence-based recommendations on encorafenib (Braftovi) plus cetuximab (Erbitux) for treating BRAF V600E mutation-positive metastatic colorectal cancer in

  4. Colorectal cancer

    Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart

  5. Lower urinary tract symptoms in men

    Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart

  6. Early and locally advanced breast cancer

    Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart

  7. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  8. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188)

    This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It also includes advice on organising services for long COVID.

  9. COVID-19 rapid guideline: vitamin D (NG187)

    This guideline covers vitamin D use in the context of COVID-19. It is for adults, young people and children in hospitals and community settings. Vitamin D is important for bone and muscle health. It may also have a role in the body's immune response to respiratory viruses.

  10. Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma (TA666)

    Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults

  11. Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura (TA667)

    Evidence-based recommendations on caplacizumab (Cablivi) with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic

  12. Eating disorders: recognition and treatment (NG69)

    This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.

  13. Type 2 diabetes in adults

    Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart

  14. Liver cancers

    Everything NICE has said on liver and bile duct cancers in an interactive flowchart

  15. Pancreatitis

    Everything NICE has said on pancreatitis in an interactive flowchart

  16. Eating disorders

    Everything NICE has said on identifying and managing eating disorders in people 8 years and over in an interactive flowchart

  17. Diabetes in children and young people

    Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart

  18. Type 1 diabetes in adults

    Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart

  19. Diabetes in pregnancy

    Everything NICE has said on managing diabetes and its complications before, during and after pregnancy in an interactive flowchart

  20. Acutely ill patients in hospital

    Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart

  21. Urogenital conditions

    Everything NICE has said on urogenital conditions in an interactive flowchart

  22. Urinary incontinence in neurological disease

    Everything NICE has said on managing lower urinary tract dysfunction resulting from neurological disease and injury in an interactive flowchart

  23. Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)

    This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes.

  24. Diabetes in pregnancy: management from preconception to the postnatal period (NG3)

    This guideline covers managing diabetes and its complications in women who are planning pregnancy or are already pregnant. It aims to improve the diagnosis of gestational diabetes and help women with diabetes to self-manage their blood glucose levels before and during pregnancy.

  25. Type 2 diabetes in adults: management (NG28)

    This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.

  26. Pancreatitis (NG104)

    This guideline covers managing acute and chronic pancreatitis in children, young people and adults. It aims to improve quality of life by ensuring that people have the right treatment and follow-up, and get timely information and support after diagnosis.

  27. Low back pain and sciatica in over 16s: assessment and management (NG59)

    This guideline covers assessing and managing low back pain and sciatica in people aged 16 and over. It outlines physical, psychological, pharmacological and surgical treatments to help people manage their low back pain and sciatica in their daily life. The guideline aims to improve people’s quality of life by promoting the most effective forms of care for low back pain and sciatica.

  28. Osteoarthritis

    Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

  29. Low back pain and sciatica

    Everything NICE has said on low back pain and sciatica in an interactive flowchart

  30. Lower limb peripheral arterial disease

    Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart

  31. Osteoarthritis: care and management (CG177)

    This guideline covers assessing and managing osteoarthritis in adults. It covers both pharmacological and non-pharmacological treatments. It promotes effective treatment options to control joint pain and improve function in people with osteoarthritis.

  32. Peripheral arterial disease: diagnosis and management (CG147)

    This guideline covers diagnosing and managing peripheral arterial disease (PAD) in people aged 18 and over. Rapid changes in diagnostic methods, endovascular treatments and vascular services associated with new specialties in surgery and interventional radiology have resulted in considerable uncertainty and variation in practice. This guideline aims to resolve that uncertainty and variation.

  33. Preventing type 2 diabetes

    Everything NICE has said on preventing type 2 diabetes in an interactive flowchart

  34. Obesity

    Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart

  35. Blood and bone marrow cancers

    Everything NICE has said on blood and bone marrow cancers including leukaemia in an interactive flowchart

  36. Parkinson's disease

    Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart

  37. Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia (TA663)

    Evidence-based recommendations on venetoclax (Venclyxto) with obinutuzumab for untreated chronic lymphocytic leukaemia in adults

  38. Liraglutide for managing overweight and obesity (TA664)

    Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in

  39. Chronic kidney disease

    Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

  40. Nutrition support in adults

    Everything NICE has said on nutrition support for adults who are malnourished or at risk of malnutrition in an interactive flowchart

  41. Food allergy in under 19s

    Everything NICE has said on diagnosing and assessing food allergy in children and young people in primary care and community settings in an interactive flowchart